JAMMU, AUGUST 16: Foods and Drugs Administration today convened a meeting of stake holders of the pharma trade fraternity to sensitize them on sale/distribution, pattern/tracking of drugs comprising habit forming ingredients viz codiene phosphate, tramadol, alprazolam etc and abortifacient drugs.
Members of Trade Associations like JKCDA, JPDA, JCA and representatives of Pharmaceutical Depot Holders along with their Authorised Stockiest(s) and Prominent Retailers were present.
During the meeting, the trade fraternity was impressed upon to regulate the sale of pre-identified brands of habit forming formulations strictly to the identified Medical Outlets i.e in and around near Primary Health Care Institutions/Medical Outlets where doctors are prescribing such drug formulations or to such counters only which have adopted computerized system of billing to meet the objective as well as to ensure that such drugs are strictly dispensed in consonance with the prescriptions only to the needy patients.
The trade fraternity was impressed upon to work with human approach so that misuse of such drugs is eradicated from the society by way of maintaining complete sale records of such drugs so as to ensure that these formulations are made available to the needy patients only and shall in no way find a place for pilferage into the hands of anti-social elements.
State Drug Controller has impressed upon the Trade Fraternity to dispense drugs comprising habit forming ingredients strictly under rules to the needy patients only, failing which action as contemplated under relevant provisions shall be initiated against the defaulters.
Pertinently, statutory drug samples of more than hundred drug formulations viz Antibiotics, PPI, Steroid, NSAIDs etc were lifted to check the identity, strength and purity of these drugs. These samples have been referred to State Drug Testing Laboratories for framing legal opinion to ascertain their quality parameters, besides operation of Six Retail Sale Outlets has been suspended for non-maintenance of sale records as mandated under the provisions of Drugs & Cosmetics Act, 1940 & rules there-under. |